161 related articles for article (PubMed ID: 29538005)
1. An evaluation of global coagulation assays in myeloproliferative neoplasm.
Lim HY; Ng C; Rigano J; Tacey M; Donnan G; Nandurkar H; Ho P
Blood Coagul Fibrinolysis; 2018 Apr; 29(3):300-306. PubMed ID: 29538005
[TBL] [Abstract][Full Text] [Related]
2. Platelet-induced thrombin generation by the calibrated automated thrombogram assay is increased in patients with essential thrombocythemia and polycythemia vera.
Panova-Noeva M; Marchetti M; Spronk HM; Russo L; Diani E; Finazzi G; Salmoiraghi S; Rambaldi A; Barbui T; Ten Cate H; Falanga A
Am J Hematol; 2011 Apr; 86(4):337-42. PubMed ID: 21442635
[TBL] [Abstract][Full Text] [Related]
3. Global coagulation in myeloproliferative neoplasms.
Tripodi A; Chantarangkul V; Gianniello F; Clerici M; Lemma L; Padovan L; Gatti L; Mannucci PM; Peyvandi F
Ann Hematol; 2013 Dec; 92(12):1633-9. PubMed ID: 23820940
[TBL] [Abstract][Full Text] [Related]
4. A comparison of global coagulation assays between normal controls and patients with thrombocytopenia.
Lim HY; Leung P; Manitta V; Nandurkar H; Ho P
Int J Lab Hematol; 2019 Apr; 41(2):184-191. PubMed ID: 30365212
[TBL] [Abstract][Full Text] [Related]
5. Global coagulation assays in healthy controls: are there compensatory mechanisms within the coagulation system?
Lim HY; Lui B; Tacey M; Selan C; Donnan G; Burrell LM; Nandurkar H; Ho P
J Thromb Thrombolysis; 2021 Aug; 52(2):610-619. PubMed ID: 33625645
[TBL] [Abstract][Full Text] [Related]
6. Global Coagulation Assays in Transgender Women on Oral and Transdermal Estradiol Therapy.
Lim HY; Leemaqz SY; Torkamani N; Grossmann M; Zajac JD; Nandurkar H; Ho P; Cheung AS
J Clin Endocrinol Metab; 2020 Jul; 105(7):. PubMed ID: 32413907
[TBL] [Abstract][Full Text] [Related]
7. Increased circulating procoagulant activity and thrombin generation in patients with myeloproliferative neoplasms.
Duchemin J; Ugo V; Ianotto JC; Lecucq L; Mercier B; Abgrall JF
Thromb Res; 2010 Sep; 126(3):238-42. PubMed ID: 20656333
[TBL] [Abstract][Full Text] [Related]
8. The evaluation of the relevance of thrombin generation and procoagulant activity in thrombotic risk assessment in BCR-ABL-negative myeloproliferative neoplasm patients.
Baccouche H; Ben Jemaa M; Chakroun A; Chadi S; Mahjoub S; Sfar I; Gorgi Y; Ben Romdhane N
Int J Lab Hematol; 2017 Oct; 39(5):502-507. PubMed ID: 28497580
[TBL] [Abstract][Full Text] [Related]
9. Dkk3 levels in patients with myeloproliferative neoplasms.
Medinger M; Muesser P; Girsberger S; Skoda R; Tzankov A; Buser A; Passweg J; Tsakiris DΑ
Thromb Res; 2014 Feb; 133(2):218-21. PubMed ID: 24309205
[TBL] [Abstract][Full Text] [Related]
10. Assessing maternal clotting function with novel global coagulation assays: A prospective pilot study.
O'Keefe D; Lim HY; Tham J; Ho P; Hui L
Int J Lab Hematol; 2021 Jun; 43(3):458-467. PubMed ID: 33174330
[TBL] [Abstract][Full Text] [Related]
11. The utility of thromboelastography and thrombin generation in assessing the prothrombotic state of adults with sickle cell disease.
Wijnberge M; Parmar K; Kesse-Adu R; Howard J; Cohen AT; Hunt BJ
Thromb Res; 2017 Oct; 158():113-120. PubMed ID: 28888622
[TBL] [Abstract][Full Text] [Related]
12. Thrombosis Risk Assessment in Myeloproliferative Neoplasm-Is There a Role for Viscoelastic Testing?
Lim HY; Ho P
Semin Thromb Hemost; 2023 Mar; 49(2):173-181. PubMed ID: 36055269
[TBL] [Abstract][Full Text] [Related]
13. The Pitfalls of Global Hemostasis Assays in Myeloproliferative Neoplasms and Future Challenges.
Tiu A; Chiasakul T; Kessler CM
Semin Thromb Hemost; 2024 Mar; 50(2):213-223. PubMed ID: 37068511
[TBL] [Abstract][Full Text] [Related]
14. Global coagulation assays in patients with chronic kidney disease and their role in predicting thrombotic risk.
Lim HY; Lui B; Tacey M; Barit D; Patel SK; Donnan G; Nandurkar H; Burrell LM; Ho P
Thromb Res; 2023 Jun; 226():127-135. PubMed ID: 37150026
[TBL] [Abstract][Full Text] [Related]
15. Use of rotational thromboelastometry for a global screening of coagulation profile in patients of myeloproliferative neoplasms.
Şahin DG; Akay OM; Uskudar Teke H; Andıc N; Gunduz E
Platelets; 2021 Feb; 32(2):280-283. PubMed ID: 32245332
[TBL] [Abstract][Full Text] [Related]
16. Global assays of fibrinolysis.
Ilich A; Bokarev I; Key NS
Int J Lab Hematol; 2017 Oct; 39(5):441-447. PubMed ID: 28497494
[TBL] [Abstract][Full Text] [Related]
17. Early thrombin formation capacity in trauma patients and association with venous thromboembolism.
Voils SA; Lemon SJ; Jordan J; Riley P; Frye R
Thromb Res; 2016 Nov; 147():13-15. PubMed ID: 27664391
[TBL] [Abstract][Full Text] [Related]
18. Global coagulation assays in hypercoagulable states.
Lim HY; Donnan G; Nandurkar H; Ho P
J Thromb Thrombolysis; 2022 Jul; 54(1):132-144. PubMed ID: 34997471
[TBL] [Abstract][Full Text] [Related]
19. Selected parameters of hemostasis in patients with myeloproliferative neoplasms.
Gadomska G; Rość D; Stankowska K; Boinska J; Ruszkowska-Ciastek B; Wieczór R
Blood Coagul Fibrinolysis; 2014 Jul; 25(5):464-70. PubMed ID: 24509338
[TBL] [Abstract][Full Text] [Related]
20. Investigation of the thrombin-generating capacity, evaluated by thrombogram, and clot formation evaluated by thrombelastography of platelets stored in the blood bank for up to 7 days.
Johansson PI; Svendsen MS; Salado J; Bochsen L; Kristensen AT
Vox Sang; 2008 Feb; 94(2):113-8. PubMed ID: 18067490
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
